Oral exemestane 25 mg/day for 2–3 years of adjuvant therapy was generally more effective than 5 years of continuous adjuvant tamoxifen in the treatment of postmenopausal women with early-stage estrogen receptor-positive/unknown receptor status breast in a large well-designed [ citation needed ] trial. Preliminary data from the open-label TEAM trial comparing exemestane with tamoxifen indicated in 2009 that exemestane 25 mg/day is also effective in the primary adjuvant treatment of early-stage breast cancer in postmenopausal women. 
This pure saponin occurs naturally in the body and increases anabolic, or tissue-building and rejuvenating, activity without any androgenic characteristics. It also guards against catabolic action in your internal system, which creates a breaking down, or destructive state that affects the tissues of your muscles, organs and bones. This substance helps reduce fat deposits in your body while it increases muscle size, density and strength as well as your energy levels. It is bonded with Cypionate, an 8 carbon ester that provides low to moderate degrees of supplement solubility in the blood as it moves through your circulatory system to help nourish and fuel your muscles and entire body.